Matthew Stanton
Stock Analyst at Jefferies
(0.36)
# 4,040
Out of 4,761 analysts
5
Total ratings
33.33%
Success rate
-18.57%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $6.22 | +28.62% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.30 | +150.00% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $26.67 | -17.51% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $44.75 | +43.02% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $6.22
Upside: +28.62%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.30
Upside: +150.00%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $26.67
Upside: -17.51%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $44.75
Upside: +43.02%